FDA Drug Application (203214) for XELJANZ by PF PRISM CV

Back to FDA Applications sponsored by PF PRISM CV

Application Number203214
Product Number001
FormTABLET;ORAL
DosageEQ 5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameXELJANZ
Active IngredientTOFACITINIB CITRATE



Back to FDA Applications sponsored by PF PRISM CV

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.